Endoscopic trans-sphenoidal adenoma resection ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 74 | Prolactin secreting pituitary adenoma | 1 |
74. Prolactin secreting pituitary adenoma
Clinical trials : 18 / Drugs : 33 - (DrugBank : 10) / Drug target genes : 16 - Drug target pathways : 65
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04107480 (ClinicalTrials.gov) | June 21, 2019 | 27/8/2019 | PRolaCT - Three Prolactinoma RCTs | PRolaCT - Three Multicenter Prolactinoma Randomized Clinical Trials | Prolactinoma;Prolactin-Producing Pituitary Tumor | Procedure: Endoscopic trans-sphenoidal adenoma resection;Drug: Dopamine Agonists | Leiden University Medical Center | NULL | Recruiting | 18 Years | N/A | All | 880 | Phase 4 | Netherlands |